SpringWorks Therapeutics, Inc.
Clinical trials sponsored by SpringWorks Therapeutics, Inc., explained in plain language.
A biopharmaceutical company developing targeted therapies for rare diseases and cancer.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Liver function and drug breakdown: a new study on mirdametinib Results expected Oct 2026 (estimated)
- New pill targets Hard-to-Treat cancers with hippo pathway mutations Results expected Jan 2027 (estimated)
- New pill shows promise for rare tumor in japanese patients Results expected May 2027 (estimated)